BioCentury
ARTICLE | Clinical News

EU approval for alofisel to treat perianal fistulas

March 30, 2018 3:37 PM UTC

TiGenix N.V. (Euronext:TIG; NASDAQ:TIG) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said the European Commission approved an MAA for Alofisel darvadstrocel to treat complex perianal fistulas in patients with Crohn's disease.

The companies said Alofisel is the first allogeneic expanded adipose derived stem cell therapy to receive centralized marketing approved in Europe...